Regulation of lacrimal gland development and regeneration

泪腺发育和再生的调节

• 批准号: 8029664
• 负责人: Helen P. Makarenkova
• 金额: $ 23.74万
• 依托单位: SCRIPPS RESEARCH INSTITUTE, THE
• 依托单位国家: 美国
• 财政年份: 2011
• 资助国家: 美国
• 起止时间: 2011-02-01 至 2013-01-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8029664
• 关键词: Adverse effects; Aging-Related Process; Autoimmune Diseases; Binding; Biological; Biological Process; Cell Differentiation process; Cell Proliferation; Chronic; Climate; Data; Development; Developmental Biology; Diffusion; Disease; Dry Eye Syndromes; Epithelial; Epithelial Cells; Extracellular Matrix; Eye; FGF10 gene; FGF3 gene; FGF7 gene; Family; Fibroblast Growth Factor; Functional disorder; Gene Expression; Gene Expression Regulation; Gene Family; Genes; Goals; Harderian Gland; Heparitin Sulfate; Hospitals; Laboratories; Lacrimal gland structure; Lead; Letters; Los Angeles; Lubrication; Mediating; Mediator of activation protein; Medical center; Mesenchymal; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Modeling; Modification; Molecular Structure; Morphogenesis; Mutation; Natural regeneration; Organ; Pathway interactions; Patients; Pharmaceutical Preparations; Pollution; Process; Property; Publications; Reagent; Regulation; Salivary Glands; Signal Pathway; Signal Transduction; Signaling Molecule; Sjogren' s Syndrome; Specificity; Structure; Syndrome; System; Time; Tissues; Translating; Work; alternative treatment; base; cell motility; computerized data processing; design; digital; eye dryness; fibroblast growth factor 10; fibroblast growth factor receptor 2b; fibroblast growth factor receptor 2c; gland development; homeodomain; member; migration; novel therapeutic intervention; proto-oncogene protein kfgf; repaired; research study; transcription factor

DESCRIPTION (provided by applicant): Dry eye syndrome is a chronic lack of sufficient lubrication in the eye due to malfunction or damage to the lacrimal gland. Dry eye may occur as a part of the natural aging process, as a side effect of many medications, as an effect of environmental causes (dry climate or pollution), or as result of an autoimmune disease (Sjogren's syndrome). Though lacrimal gland function has been well studied, relatively little is known about the mechanisms that regulate lacrimal gland development. Our long-term goal is to define these mechanisms and to create a comprehensive model of lacrimal gland development that could be critical for designing alternative treatments for patients with lacrimal gland disorders. Our previous studies showed that members of the fibroblast growth factor (FGF) family are important regulators of lacrimal gland morphogenesis. In particular we found that FGF-10 was necessary for lacrimal and Harderian gland development. Moreover, recent studies have identified mutations in FGF10 in patients with aplasia of the lacrimal and salivary glands (ALSG) and in lacrimo-auriculo-dento-digital (LADD) syndrome. Together these studies established that FGF signaling is important for lacrimal gland development. Over the past two years, we have made significant advances in understanding how structural differences in various FGFs are incorporated into their functional properties. Thus we showed that differences in the binding of FGF7 and FGF10 to heparan sulfate (HS) within the extracellular matrix result in the formation of different gradients that dictate distinct functional activities of these FGFs during branching morphogenesis. These data for the first time connected the structural differences of FGFs with their biological function in LG branching morphogenesis. Our preliminary studies have also shown that FGFs cooperate with canonical Wnt/2-catenin signaling and the homeodomain transcription factor Barx2 in regulating of lacrimal gland morphogenesis. We now propose to focus our efforts on defining structural basis for distinct functions of different FGFs in LG branching morphogenesis (Aim 1). In this aim we will perform a comprehensive functional study of mutations in FGF3 and FGF10 structure. In addition, we will evaluate the regulatory connections between FGF and Wnt signaling pathways and the transcription factor Barx2 in controlling lacrimal gland cell proliferation and differentiation (Aim 2). Understanding the mechanistic details of the FGF signaling in lacrimal gland morphogenesis will have broad significance in the field of developmental biology and will, in the long-term, help the development of novel therapeutic approaches for treatment of patients with dry eye conditions. PUBLIC HEALTH RELEVANCE: In this application we will focus on understanding the regulatory mechanisms that control lacrimal gland branching and repair. Our long-term goal is to define these mechanisms and to create a comprehensive model of lacrimal gland development that could be critical for designing alternative treatments for patients with lacrimal gland disorders.

描述（由申请人提供）：干眼综合征是由于泪腺功能障碍或损伤导致的眼睛长期缺乏足够的润滑。干眼症可能是自然衰老过程的一部分，可能是许多药物的副作用，可能是环境原因（干燥气候或污染）的影响，也可能是自身免疫性疾病（干燥综合征）的结果。虽然泪腺的功能已经得到了很好的研究，但对泪腺发育的调节机制却知之甚少。我们的长期目标是确定这些机制，并建立一个全面的泪腺发育模型，这对于设计治疗泪腺疾病患者的替代疗法至关重要。我们之前的研究表明，成纤维细胞生长因子（FGF）家族成员是泪腺形态发生的重要调节因子。我们特别发现FGF-10对于泪腺和哈德氏腺的发育是必需的。此外，最近的研究发现，在泪腺和唾液腺发育不全（ALSG）和泪-耳-齿-指（LADD）综合征患者中，FGF10发生了突变。综上所述，这些研究证实FGF信号传导对泪腺发育很重要。在过去的两年中，我们在了解各种FGFs的结构差异如何被纳入其功能特性方面取得了重大进展。因此，我们发现在细胞外基质中，FGF7和FGF10与硫酸肝素（HS）结合的差异导致不同梯度的形成，这些梯度决定了这些FGFs在分支形态发生过程中的不同功能活动。这些数据首次将FGFs的结构差异与其在LG分支形态发生中的生物学功能联系起来。我们的初步研究也表明，FGFs与典型的Wnt/2-catenin信号和同源结构域转录因子Barx2协同调节泪腺形态发生。我们现在建议将重点放在确定不同fgf在LG分支形态发生中不同功能的结构基础上（目的1）。为此，我们将对FGF3和FGF10结构突变进行全面的功能研究。此外，我们将评估FGF和Wnt信号通路以及转录因子Barx2在控制泪腺细胞增殖和分化中的调控联系（目的2）。了解泪腺形态发生中FGF信号的机制细节将在发育生物学领域具有广泛意义，并且从长远来看，将有助于开发治疗干眼症患者的新治疗方法。